Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study.

NCT01250782 is registered in ClinicalTrials.gov with Hospital Universitari Son Dureta as lead sponsor.

NCT NCT01250782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01250782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study.
Lead sponsor
Hospital Universitari Son Dureta
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2010
Completion date
October 31, 2012
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trauma icu patients